Loss of exclusivity of ceftazidime/avibactam in low- and middle-income countries: a test for antibiotic stewardship practice
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Psychiatry and Mental health,Public Health, Environmental and Occupational Health
Reference16 articles.
1. Is it time to move away from polymyxins?: evidence and alternatives;Soman;Eur J Clin Microbiol Infect Dis,2021
2. AVYCAZ, ceftazidime pentahydrate & avibactam sodium. Applications for patent term extension and patent terms extended under 35 U.S.C. § 156,2023
3. Management of serious infections caused by metallo β-lactamases with or without OXA-48-like expressing Enterobacterales with aztreonam and ceftazidime/avibactam combination: dosing strategy for better clinical outcome;Veeraraghavan;Indian J Med Microbiol,2021
4. High prevalence of Escherichia coli clinical isolates in India harbouring four amino acid inserts in PBP3 adversely impacting activity of aztreonam/avibactam;Periasamy;J Antimicrob Chemother,2020
5. Activity of aztreonam in combination with ceftazidime–avibactam against serine-and metallo-β-lactamase–producing Pseudomonas aeruginosa;Lee;Diagn Microbiol Infect Dis,2021
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Failure of ceftazidime/avibactam experimental therapy in the treatment of Klebsiella pneumoniae ST11 co-producing NDM-1 and OXA-48 carbapenemases infection;European Journal of Clinical Microbiology & Infectious Diseases;2024-07-29
2. Improved Blue Carba test and Carba NP test for detection and classification of major Class A and B carbapenemases, including dual producers, among Gram-negative bacilli;Journal of Clinical Microbiology;2024-07-16
3. Are we looking towards an early demise of ceftazidime/avibactam (CAZ/AVI) as an antibiotic?;Indian Journal of Medical Microbiology;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3